Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      First patient treated in the second dose group in Annexin’s RVO study
      Biotech

      First patient treated in the second dose group in Annexin’s RVO study

      October 25, 2023
      UNION therapeutics to present at 7th Annual Dermatology Drug Development Summit in Boston
      Biotech

      UNION therapeutics to present at 7th Annual Dermatology Drug Development Summit in Boston

      October 25, 2023
      Samsung Biologics reports third quarter 2023 financial results
      Biotech

      Samsung Biologics reports third quarter 2023 financial results

      October 25, 2023
      Phanes Therapeutics, Inc. Announces Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate PT886 in Combination with KEYTRUDA® (pembrolizumab)
      Biotech

      Phanes Therapeutics, Inc. Announces Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate PT886 in Combination with KEYTRUDA® (pembrolizumab)

      October 16, 2023
      IDEAYA Biosciences Announces Phase 2 Expansion of Darovasertib and Crizotinib Combination in GNAQ/11 Metastatic Cutaneous Melanoma
      Biotech

      IDEAYA Biosciences Announces Phase 2 Expansion of Darovasertib and Crizotinib Combination in GNAQ/11 Metastatic Cutaneous Melanoma

      October 16, 2023
      SOTIO Enters Licensing Agreement With Synaffix to Expand ADC Pipeline
      Biotech

      SOTIO Enters Licensing Agreement With Synaffix to Expand ADC Pipeline

      October 16, 2023
      Ryvu Therapeutics Presents Preclinical Data on PRMT5 and its Synthetic Lethality Platform at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
      Biotech

      Ryvu Therapeutics Presents Preclinical Data on PRMT5 and its Synthetic Lethality Platform at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

      October 16, 2023
      Global Plasmid DNA Manufacturing Research Analysis Report 2023-2035: Expansion of Facilities for Building GMP Plasmid Manufacturing Capabilities
      Biotech

      Global Plasmid DNA Manufacturing Research Analysis Report 2023-2035: Expansion of Facilities for Building GMP Plasmid Manufacturing Capabilities

      October 13, 2023
      Hyundai Bioscience announces that “Xafty is the only antiviral that can be immediately used for the treatment of Dengue fever”
      Biotech

      Hyundai Bioscience announces that “Xafty is the only antiviral that can be immediately used for the treatment of Dengue fever”

      October 13, 2023
      Vitrolife AB (publ): Conference call interim report
      Biotech

      Vitrolife AB (publ): Conference call interim report

      October 13, 2023
      « 1 … 101 102 103 104 105 … 151 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026